Wu et al., in their study of 537 women with adenomyosis that GnRH agonist down-regulation followed by FET, was associated with significantly better implantation and live birth rates and lower miscarriage rates when compared to fresh embryo transfer following an ultralong GnRH agonist protocol for ovarian stimulation. This evidence concerns the gene GNRH1 and adenomyosis.